Hepatitis C virus infection in intravenous drug users

被引：17
|
作者：
Harder, J
Walter, E
Riecken, B
Ihling, C
Bauer, TM
机构：
[1] Univ Freiburg, Med Klin, Innere Med Abt 2, Dept Pathol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Univ Hosp, Dept Med Gastroenterol Hepatol & Infect Dis 2, Freiburg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期
关键词：
drug users; hepatitis C; liver function tests; liver histology;
D O I：
10.1111/j.1469-0691.2004.00934.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Intravenous drug use (IVDU) remains a major means of hepatitis C virus (HCV) transmission. In this study, 101 drug users were studied prospectively after cessation of IVDU. Of these, 75.8% were anti-HCV positive, and 71.4% had elevated levels of alanine aminotransferase. These levels decreased significantly within 1 month of IVDU cessation (p 0.02). Liver biopsies showed minimal or mild fibrosis in 32 (71%) of 45 subjects, and severe fibrosis in two (4.4%) subjects. Anti-HCV-positive intravenous drug users in this study presented with mild liver disease and variable stages of disease progression. Biochemical disease activity might be affected by IVDU.
引用
收藏
页码：768 / 770
页数：3
相关论文
共 50 条
  • [1] Treatment of hepatitis C virus infection in intravenous drug users
    Cowan, Matthew L.
    Maxwell, James D.
    ACTA NEUROPSYCHIATRICA, 2006, 18 (05): : 183 - 192
  • [2] Recommendations for the management of hepatitis C virus infection among intravenous drug users
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 111
  • [3] Factors associated with persistent hepatitis G virus and hepatitis C virus infection in intravenous drug users.
    Toniutto, P
    Gasparini, V
    Fabris, C
    Lombardelli, T
    Falleti, E
    Mattiuzzo, M
    Maurizio, R
    Pirisi, M
    HEPATOLOGY, 1997, 26 (04) : 1952 - 1952
  • [4] Viral infection of hepatitis C and B in intravenous drug users
    Garotic-Ilic, L.
    Vlatkovic-Ilic, V.
    Babic-Dunjic, V.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 193 - 193
  • [5] Management of hepatitis C virus infections in intravenous drug users
    Robaeys, G
    Matheï, C
    Buntinx, F
    Vanranst, M
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 99 - 100
  • [6] HEPATITIS-C VIRUS IN INTRAVENOUS-DRUG-USERS
    BELL, J
    BATEY, RG
    FARRELL, GC
    CREWE, EB
    CUNNINGHAM, AL
    BYTH, K
    MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (05) : 274 - 276
  • [7] Prevention of hepatitis C virus infection in drug users
    Schulte, B.
    Stoever, H.
    Leicht, A.
    Schnackenberg, K.
    Reimer, J.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (10) : 1210 - 1217
  • [8] The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users
    Haydon, GH
    Flegg, PJ
    Blair, CS
    Brettle, RP
    Burns, SM
    Hayes, PC
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (06) : 485 - 489
  • [9] Hepatitis G virus infection in intravenous drug users with or without human immunodeficiency virus infection
    Campo, N
    Brizzolara, R
    Sinelli, N
    Puppo, F
    Campelli, A
    Indiveri, F
    Picciotto, A
    HEPATO-GASTROENTEROLOGY, 2000, 47 (35) : 1385 - 1388
  • [10] Prevalence of hepatitis C infection among intravenous drug users in Shanghai
    Tao, Yan-Lin
    Tang, Yu-Fan
    Qiu, Jian-Ping
    Cai, Xiao-Feng
    Shen, Xiao-Ting
    Wang, Ya-Xin
    Zhao, Xue-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (32) : 5320 - 5325
12345